Cargando…
Do patients with soft-tissue sarcomas treated with trabectedin have better clinical effects and a longer survival time than those treated with doxorubicin?
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9073773/ https://www.ncbi.nlm.nih.gov/pubmed/35530946 http://dx.doi.org/10.21037/atm-21-7018 |
| _version_ | 1784701360367730688 |
|---|---|
| author | Wu, Jiangfeng Zhang, Maoliang Chen, Chunting Zhao, Anli Guo, Yinghong |
| author_facet | Wu, Jiangfeng Zhang, Maoliang Chen, Chunting Zhao, Anli Guo, Yinghong |
| author_sort | Wu, Jiangfeng |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9073773 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | AME Publishing Company |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-90737732022-05-07 Do patients with soft-tissue sarcomas treated with trabectedin have better clinical effects and a longer survival time than those treated with doxorubicin? Wu, Jiangfeng Zhang, Maoliang Chen, Chunting Zhao, Anli Guo, Yinghong Ann Transl Med Letter to the Editor AME Publishing Company 2022-04 /pmc/articles/PMC9073773/ /pubmed/35530946 http://dx.doi.org/10.21037/atm-21-7018 Text en 2022 Annals of Translational Medicine. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
| spellingShingle | Letter to the Editor Wu, Jiangfeng Zhang, Maoliang Chen, Chunting Zhao, Anli Guo, Yinghong Do patients with soft-tissue sarcomas treated with trabectedin have better clinical effects and a longer survival time than those treated with doxorubicin? |
| title | Do patients with soft-tissue sarcomas treated with trabectedin have better clinical effects and a longer survival time than those treated with doxorubicin? |
| title_full | Do patients with soft-tissue sarcomas treated with trabectedin have better clinical effects and a longer survival time than those treated with doxorubicin? |
| title_fullStr | Do patients with soft-tissue sarcomas treated with trabectedin have better clinical effects and a longer survival time than those treated with doxorubicin? |
| title_full_unstemmed | Do patients with soft-tissue sarcomas treated with trabectedin have better clinical effects and a longer survival time than those treated with doxorubicin? |
| title_short | Do patients with soft-tissue sarcomas treated with trabectedin have better clinical effects and a longer survival time than those treated with doxorubicin? |
| title_sort | do patients with soft-tissue sarcomas treated with trabectedin have better clinical effects and a longer survival time than those treated with doxorubicin? |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9073773/ https://www.ncbi.nlm.nih.gov/pubmed/35530946 http://dx.doi.org/10.21037/atm-21-7018 |
| work_keys_str_mv | AT wujiangfeng dopatientswithsofttissuesarcomastreatedwithtrabectedinhavebetterclinicaleffectsandalongersurvivaltimethanthosetreatedwithdoxorubicin AT zhangmaoliang dopatientswithsofttissuesarcomastreatedwithtrabectedinhavebetterclinicaleffectsandalongersurvivaltimethanthosetreatedwithdoxorubicin AT chenchunting dopatientswithsofttissuesarcomastreatedwithtrabectedinhavebetterclinicaleffectsandalongersurvivaltimethanthosetreatedwithdoxorubicin AT zhaoanli dopatientswithsofttissuesarcomastreatedwithtrabectedinhavebetterclinicaleffectsandalongersurvivaltimethanthosetreatedwithdoxorubicin AT guoyinghong dopatientswithsofttissuesarcomastreatedwithtrabectedinhavebetterclinicaleffectsandalongersurvivaltimethanthosetreatedwithdoxorubicin |